Cargando…
BIX01294, an inhibitor of histone methyltransferase, induces autophagy-dependent differentiation of glioma stem-like cells
Glioblastoma (GBM) contains rare glioma stem-like cells (GSCs) with capacities of self-renewal, multi-lineage differentiation, and resistance to conventional therapy. Drug-induced differentiation of GSCs is recognized as a promising approach of anti-glioma therapy. Accumulating evidence suggests tha...
Autores principales: | Ciechomska, Iwona Anna, Przanowski, Piotr, Jackl, Judyta, Wojtas, Bartosz, Kaminska, Bozena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146656/ https://www.ncbi.nlm.nih.gov/pubmed/27934912 http://dx.doi.org/10.1038/srep38723 |
Ejemplares similares
-
Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to Temozolomide
por: Ciechomska, Iwona Anna, et al.
Publicado: (2018) -
The Histone Methyltransferase Inhibitor BIX01294 Inhibits HIF-1α Stability and Angiogenesis
por: Oh, Su Young, et al.
Publicado: (2015) -
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
por: Chang, Yanqi, et al.
Publicado: (2009) -
Examining the effects of the histone methyltransferase inhibitor BIX-01294 on histone modifications and gene expression in both a clinical population and mouse models
por: Chase, Kayla A., et al.
Publicado: (2019) -
Modulation of microRNA expression in human lung cancer cells by the G9a histone methyltransferase inhibitor BIX01294
por: PANG, ALAN LAP-YIN, et al.
Publicado: (2014)